Back to discover
Disease

Psychoses, Substance-Induced

Late-stage therapeutic developmentEmerging researchRising momentum
MeSHPsychoses, Substance-Induced
3
Publications
1
Clinical trials
2025
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
1
Late-stage
1
Completed
Late-stage studies

Prevention of NMDA Antagonist-induced Psychosis and Memory Impairment in Children

Phase 4 · Completed · Washington University School of Medicine
Recently completed

Prevention of NMDA Antagonist-induced Psychosis and Memory Impairment in Children

Phase 4 · Completed · Washington University School of Medicine

Research activity

3 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20052025
Major themes3
  • Hallucinogens2
  • Psychoses, Substance-Induced2
  • Psychotic Disorders1
Leading journals3
  • BMJ (Clinical research ed.)1
  • Molecular psychiatry1
  • The International journal on drug policy1
Leading researchers8
  • Böge K1
  • Correll CU1
  • Curtis L1
  • De Pieri M1
  • Gashi L1
  • Glangetas A1
  • Henquet C1
  • Kaiser S1
Affiliations (unnormalised)6
  • Charité Universitätsmedizin1
  • Charité-Universitätsmedizin Berlin1
  • Charité-Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin; and Berlin Institute of Health1
  • Département Médical-Universitaire de Psychiatrie et d'Addictologie1
  • Donald and Barbara Zucker School of Medicine at Hofstra/Northwell1
  • Geneva University Hospital1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.

Identifiers
MeSHPsychoses, Substance-Induced
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.